According to health professionals, Mycoplasma genitalium is developing resistance to antibiotics at an alarming rate. Much like chlamydia, many people do not know when they have it, but it can...
SpeeDx Pty. Ltd. are among the recipients of the New South Wales Medical Devices Fund (MDF) 2017-2018, announced last night. SpeeDx was granted a second MDF award of A$2.5 million...
Strategic commercial partnership in key European markets with Cepheid. SYDNEY, AUSTRALIA--(Marketwired - Jun 8, 2017) - SpeeDx Pty, Ltd., a developer of innovative molecular diagnostic solutions, today announced an agreement with...
SpeeDx Pty. Ltd. announced the publication of a novel technology, ‘Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection of SNPs and Clustered Mutations in qPCR’ in PLOS One...
Mycoplasma genitalium (MG) is one of the fastest growing STIs in the world and has been reported to have a higher incidence than gonorrhea. It has developed serious treatment challenges...
ResistancePlus® MG rapidly and reliably detects the disease and determines antibiotic resistance of this increasingly resistant sexually transmitted infection. SpeeDx Pty. Ltd. announced that the study, “Evaluation of a commercial multiplex...
SpeeDx Pty. Ltd. has received CE-IVD marking for its ResistancePlus® MG assay that detects both the sexually transmitted disease (STD) Mycoplasma genitalium (often referred to as M. genitalium or MG)...
SpeeDx Pty. Ltd. has received TGA approval for its PlexPCR® HSV-1&2, VZV multiplex qPCR kit. The test offers a single-well solution to cover the detection and differentiation of three herpes...
SpeeDx has received CE-IVD marking for its PlexPCR® HSV-1&2, VZV multiplex qPCR kit. The new multiplex molecular diagnostic test offers a single-well solution to cover the detection and differentiation of three...
Announcing the first publication for our ResistancePlus® MG assay, published in PLOS ONE in collaboration with Sepehr Tabrizi, PhD at the Royal Women’s Hospital in Melbourne, Australia. “The SpeeDx assay provides...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |